US 11485793
Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 11485793 (Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 44
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/6849